EDGAR Filing Documents for 0001144204-12-038947

Form 8-K - Current report:

SEC Accession No. 0001144204-12-038947

Filing Date

2012-07-11

Accepted

2012-07-11 12:40:34

Documents

Period of Report

2012-07-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v318213_8k.htm	8-K	27333
2	EXHIBIT 10.1	v318213_ex10-1.htm	EX-10.1	862542
3	EXHIBIT 10.2	v318213_ex10-2.htm	EX-10.2	250954
4	EXHIBIT 10.3	v318213_ex10-3.htm	EX-10.3	86804
	Complete submission text file	0001144204-12-038947.txt		1229133

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158

Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300

NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)